Organization · Venture Capital
H.I.G. BioVentures
H.I.G. BioVentures is a life sciences investment affiliate of H.I.G. Capital, focusing on early to mid-stage investments in healthcare companies. It leverages the broader H.I.G. platform to enhance operational resources for its portfolio.
Overview
What H.I.G. BioVentures does
What H.I.G. BioVentures is
H.I.G. BioVentures is a life sciences investment affiliate of H.I.G. Capital, focusing on early to mid-stage investments in healthcare companies. It leverages the broader H.I.G. platform to enhance operational resources for its portfolio.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2011
- Approximate age
- About 15 years
- Structured capabilities
- Funder
- Last reviewed
- March 18, 2026
Official channels
Find H.I.G. BioVentures elsewhere
Open the official website or a supported primary organization account.
Capability profile
H.I.G. BioVentures as a funder
Investment thesis
H.I.G. BioVentures focuses on investing in growth-stage healthcare companies across the life sciences spectrum, aiming to improve patient outcomes while reducing healthcare costs.
Focus narrative
H.I.G. BioVentures primarily invests in medical devices, biopharmaceuticals, digital health tools, and product-related services. The firm engages in various post-investment activities, including go-to-market strategies, management recruitment, and business development, to enhance the growth and success of its portfolio companies.
Value beyond capital
H.I.G. BioVentures adds value to its portfolio companies through strategic guidance in operational excellence, growth initiatives, and access to a vast network of resources within the H.I.G. Capital platform, enhancing their potential for successful exits.
Terms and economics
- Typical check
- $5,000,000–$40,000,000
Focus and fit
- Stages
- Growth Equity
- Sectors
- Healthcare · Biotech · Medical Devices · Digital Health
- Regions
- Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 50
- Recorded notable exits
- Intact Vascular, Vertiflex, Neuwave Medical, and Hyperbranch Medical
Portfolio context
H.I.G. BioVentures has invested in notable companies such as Alder Biopharmaceuticals, which develops novel antibody therapeutics; Arvelle Therapeutics, focusing on CNS disorders; and Augmedics, known for its augmented reality surgical navigation system. Other significant investments include Click Therapeutics, which creates software as prescription medical treatments, and Intact Vascular, specializing in minimally invasive vascular products.
Common questions
What to know about H.I.G. BioVentures
Upseed classifies H.I.G. BioVentures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 18, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.